Complement Component C3 and C4 in Patients COVID-19 Induced Cytokine Released Storm

被引:0
作者
Aljwaid, Husam Oudah [1 ]
Ghali, Thamer J. [1 ]
Al-Hisnawi, Ali A. [2 ,3 ]
Abass, Kasim Sakran [4 ]
机构
[1] Natl Univ Sci & Technol, Coll Med Technol, Dept Med Lab Tech, Thi Qar, Iraq
[2] Univ Kerbala, Coll Sci, Dept Biol, Kerbala, Iraq
[3] Univ Kerbala, Coll Sci, Unit Al Razzaza Lake & West Euphrates River, Kerbala, Iraq
[4] Univ Kirkuk, Coll Pharm, Dept Pharmacol & Toxicol, Kirkuk, Iraq
来源
PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES | 2021年 / 15卷 / 03期
关键词
Complement; Thi-Qar; C3; C4; COVID-19; Cytokine; REACTIVE PROTEIN; RECEPTOR; INTERLEUKIN-6; IL-6;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim: To evolution the complement component C3 and C4 in patients COVID-19 induced cytokine released storm. Methods: The case control study was conducted in Imam AL-Hussain Hospital in Thi-Qar Governorate from February 2020 to September 2020. In our study was forty of them with cytokine storm-induce SARS-COVID 19 depended on clinical feature and lab testing. Hence, fifty persons normally as a control group. The age group between 25 to up to 80 age and both gender included in the current study. Results: The level of IL6 in patients was 107.41 +/- 18.18 Pg/ml, this value showed to be in cytokine storm phenomenon while the control group was 17.41 +/- 5.45 Pg/ml. The differences were highly significant different (P= 0.00). Complement component of C3 and C4 levels of infected patient were (2.47 +/- 0.399) and (0.655 +/- 0.133), respectively showed highly elevated than the normal range. Conclusion: However, ferritin was out of the rang (>2000 ng/mL) and C-reactive protein (CRP) was highly elevated (134.05 +/- 22.67mg/L) showed highly elevated than the normal range. The mean of was ranged interleukin 6 >107.41, ferritin >2000 ng/mL, while, C.R. Protein 134.05mg/L suggested patient with cytokine release storm. However, several anti-cytokine approaches have proven effective in reversing cytokine storm syndromes.
引用
收藏
页码:1211 / 1214
页数:4
相关论文
共 35 条
  • [11] CL-L1 and CL-K1 Exhibit Widespread Tissue Distribution With High and Co-Localized Expression in Secretory Epithelia and Mucosa
    Hansen, Soren W. K.
    Aagaard, Josephine B.
    Bjerrum, Karen B.
    Hejbol, Eva K.
    Nielsen, Ole
    Schroder, Henrik D.
    Skjoedt, Karsten
    Sorensen, Anna L.
    Graversen, Jonas H.
    Henriksen, Maiken L.
    [J]. FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [12] On the Alert for Cytokine Storm: Immunopathology in COVID-19
    Henderson, Lauren A.
    Canna, Scott W.
    Schulert, Grant S.
    Volpi, Stefano
    Lee, Pui Y.
    Kernan, Kate F.
    Caricchio, Roberto
    Mahmud, Shawn
    Hazen, Melissa M.
    Halyabar, Olha
    Hoyt, Kacie J.
    Han, Joseph
    Grom, Alexei A.
    Gattorno, Marco
    Ravelli, Angelo
    De Benedetti, Fabrizio
    Behrens, Edward M.
    Cron, Randy Q.
    Nigrovic, Peter A.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2020, 72 (07) : 1059 - 1063
  • [13] The innate pattern recognition molecule Ficolin-1 is secreted by monocytes/macrophages and is circulating in human plasma
    Honore, Christian
    Rorvig, Sara
    Munthe-Fog, Lea
    Hummelshoj, Tina
    Madsen, Hans O.
    Borregaard, Niels
    Garred, Peter
    [J]. MOLECULAR IMMUNOLOGY, 2008, 45 (10) : 2782 - 2789
  • [14] Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia A systematic review, meta analysis, and meta-regression
    Huang, Ian
    Lim, Michael Anthonius
    Pranata, Raymond
    [J]. DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2020, 14 (04) : 395 - 403
  • [15] IL-6 as a keystone cytokine in health and disease
    Hunter, Christopher A.
    Jones, Simon A.
    [J]. NATURE IMMUNOLOGY, 2015, 16 (05) : 448 - 457
  • [16] Interleukin-6, A Cytokine Critical to Mediation of Inflammation, Autoimmunity and Allograft Rejection: Therapeutic Implications of IL-6 Receptor Blockade
    Jordan, Stanley C.
    Choi, Jua
    Kim, Irene
    Wu, Gordon
    Toyoda, Mieko
    Shin, Bonga
    Vo, Ashley
    [J]. TRANSPLANTATION, 2017, 101 (01) : 32 - 44
  • [17] Current concepts in the diagnosis and management of cytokine release syndrome
    Lee, Daniel W.
    Gardner, Rebecca
    Porter, David L.
    Louis, Chrystal U.
    Ahmed, Nabil
    Jensen, Michael
    Grupp, Stephan A.
    Mackall, Crystal L.
    [J]. BLOOD, 2014, 124 (02) : 188 - 195
  • [18] Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases
    Magro, Cynthia
    Mulvey, J. Justin
    Berlin, David
    Nuovo, Gerard
    Salvatore, Steven
    Harp, Joanna
    Baxter-Stoltzfus, Amelia
    Laurence, Jeffrey
    [J]. TRANSLATIONAL RESEARCH, 2020, 220 : 1 - 13
  • [19] The first case of COVID-19 treated with the complement C3 inhibitor AMY-101
    Mastaglio, Sara
    Ruggeri, Annalisa
    Risitano, Antonio M.
    Angelillo, Piera
    Yancopoulou, Despina
    Mastellos, Dimitrios C.
    Huber-Lang, Markus
    Piemontese, Simona
    Assanelli, Andrea
    Garlanda, Cecilia
    Lambris, John D.
    Ciceri, Fabio
    [J]. CLINICAL IMMUNOLOGY, 2020, 215
  • [20] COVID-19: consider cytokine storm syndromes and immunosuppression
    Mehta, Puja
    McAuley, Daniel F.
    Brown, Michael
    Sanchez, Emilie
    Tattersall, Rachel S.
    Manson, Jessica J.
    [J]. LANCET, 2020, 395 (10229) : 1033 - 1034